Armada Hoffler Announces 12,000-Square-Foot Atlantic Union Bank Lease at Town Center of Virginia Beach
Globenewswire· 2025-10-29 10:00
Core Insights - Atlantic Union Bank has signed a full floor lease for approximately 12,000 square feet at One Columbus Center, contributing to a 99% occupancy rate for Armada Hoffler's office portfolio in Town Center of Virginia Beach [1][2] Company Overview - Armada Hoffler is a vertically integrated, self-managed real estate investment trust (REIT) with over four decades of experience in developing, building, acquiring, and managing high-quality office, retail, and multifamily properties primarily in the Mid-Atlantic and Southeastern United States [4] Market Position - The decision by Atlantic Union Bank to lease space at One Columbus Center highlights Town Center of Virginia Beach as a premier business address in the Hampton Roads region, indicating strong demand for high-quality office space [2][3] - The mixed-use environment of Town Center is attracting companies, enhancing the appeal of the area for both employees and clients [2] Transaction Details - The new lease represents an immediate backfill of recently available space at a nearly 7% spread over the prior tenant's lease [1] - Divaris Real Estate represented the landlord, while Cushman & Wakefield Thalhimer represented the tenant in this transaction [3]
OMS Energy Technologies Inc. Inks Technical Service Partner Contract with a Major Thai Oil and Gas Operator
Globenewswire· 2025-10-29 10:00
Core Insights - OMS Energy Technologies Inc. is expanding its partnership with a major oil and gas operator in Thailand, reflecting the operator's confidence in OMS Thailand's technical capabilities and service quality [1][3] Company Overview - OMS Energy Technologies Inc. is a growth-oriented manufacturer specializing in surface wellhead systems (SWS) and oil country tubular goods (OCTG) for the oil and gas industry, serving both onshore and offshore operators [4] - The company operates 11 strategically located manufacturing facilities across the Asia Pacific, Middle Eastern, and North African regions, ensuring rapid response and customized solutions [4] Service Expansion - OMS Thailand has been awarded a Technical Service Partner Contract, which includes technical consultancy, gauging management, and hardware services, indicating a deepening collaboration with a key player in Thailand's oil and gas sector [1][3] - The facilities in Songkhla and Sattahip have over 20 and 10 years of service experience, respectively, and are fully licensed to support the OCTG sector with various services [2] Operational Excellence - OMS Thailand is recognized as one of Thailand's largest single-operator machine shops, meeting stringent performance and vendor selection criteria through quality control and responsive maintenance [2] - The company emphasizes a culture of precision, innovation, and reliability, which is crucial for maintaining its competitive edge in the industry [3]
Amplify Energy Announces Divestiture of East Texas Assets
Globenewswire· 2025-10-29 10:00
Core Viewpoint - Amplify Energy Corp. is executing a strategic divestiture of its East Texas assets, expecting a total consideration of $127.5 million, which will enhance its balance sheet and allow the company to focus on higher upside opportunities [1][2][3]. Group 1: Transactions Overview - The company has sold its remaining interest in the Haynesville basin for net proceeds of $5.5 million, which closed on October 24, 2025 [6]. - A definitive agreement has been made to sell the remaining Haynesville and Cotton Valley interests for a contract price of $122 million, expected to close by the end of Q4 2025 [6]. Group 2: Strategic Implications - The divestiture aligns with the company's strategic plan to simplify its portfolio and enhance liquidity, with proceeds aimed at debt reduction [2][3]. - Following the completion of the East Texas transaction, the company anticipates a significant reduction in general and administrative costs [2]. Group 3: Leadership Insights - The CEO of Amplify Energy emphasized the importance of this transaction in unlocking value from the company's most promising areas, specifically Beta and Bairoil [3]. - The CEO also acknowledged the efforts of the team in executing these transactions while maintaining safe and efficient operations [3]. Group 4: Company Profile - Amplify Energy Corp. is an independent oil and natural gas company focused on the acquisition, development, and production of oil and natural gas properties, primarily in Southern California, the Rockies, and Oklahoma [4].
Liberty Gold Reports New High-Grade Oxide Gold Drill Intercepts at Discovery Zone, Black Pine Gold Project, Idaho
Globenewswire· 2025-10-29 10:00
1.53 g/t Au over 85.3 meters, including 5.19 g/t Au over 9.1 meters in LBP1171 1.17 g/t Au over 59.4 meters, including 3.44 g/t Au over 15.2 meters in LBP1155 VANCOUVER, British Columbia, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Liberty Gold Corp. (TSX: LGD; OTCQX: LGDTF) (“Liberty Gold” or the “Company”) is pleased to announce strong oxide gold assays from nine infill drill holes in the Discovery Zone at its Black Pine Gold Project (“Black Pine”) in southeastern Idaho. These results are part of the ongoing ~40,00 ...
Osisko Intersects 592 Metres Averaging 0.33% Cu at Gaspé
Globenewswire· 2025-10-29 10:00
Core Viewpoint - Osisko Metals has announced new drill results from the Gaspé Copper Project, confirming and expanding the resource model with significant copper and molybdenum mineralization, particularly in the southern extension of the deposit [1][2][29]. Summary by Category Drill Results - The latest drilling results include 33 mineralized intercepts from nine new drill holes, with infill intercepts aimed at upgrading inferred resources and expansion intercepts potentially leading to additional resources [5][8]. - Notable drill holes include: - **30-1107**: 592.0 metres averaging 0.33% Cu (0.46 CuEq) [9] - **30-1112**: 868.5 metres averaging 0.23% Cu (0.30 CuEq) [9] - **30-1114**: 142.1 metres averaging 0.39% Cu (0.47 CuEq) [9] - **30-1116**: 565.5 metres averaging 0.22% Cu (0.29 CuEq) [9] - **30-1119**: 46.4 metres averaging 1.10% Cu (1.25 CuEq) [9] Market Context - The copper spot price is nearing US$5/lb, silver at US$47/oz, and molybdenum over US$30/lb, indicating a favorable market environment for the project [2]. Resource Expansion - The current drill program aims to convert the November 2024 Mineral Resource Estimate (MRE) to Measured and Indicated categories and test for deeper and lateral expansions towards Needle East and Needle Mountain [21][29]. - The Gaspé Copper project hosts the largest undeveloped copper resource in eastern North America, with current Indicated Mineral Resources of 824 million tonnes averaging 0.34% CuEq and Inferred Mineral Resources of 670 million tonnes averaging 0.38% CuEq [29][30]. Geological Insights - Mineralization at Gaspé Copper is characterized as porphyry copper/skarn type, with significant stockwork mineralization and high molybdenum grades observed in certain zones [18][19].
Radware Reports Third Quarter 2025 Financial Results
Globenewswire· 2025-10-29 10:00
Core Insights - Radware reported a strong performance in Q3 2025, with revenue reaching $75.3 million, an 8% increase year-over-year, and a notable acceleration in Cloud Annual Recurring Revenue (ARR) growth to 24% [3][9][10]. Financial Performance - Revenue for Q3 2025 was $75.3 million, compared to $69.5 million in Q3 2024, marking an 8% increase [3][22]. - GAAP net income for Q3 2025 was $5.7 million, or $0.13 per diluted share, up from $3.1 million, or $0.07 per diluted share, in Q3 2024 [3][22]. - Non-GAAP net income for Q3 2025 was $12.6 million, or $0.28 per diluted share, compared to $10.2 million, or $0.23 per diluted share, in Q3 2024 [3][22]. Cash Position - As of September 30, 2025, the company had cash, cash equivalents, short-term and long-term bank deposits, and marketable securities totaling $454.6 million [4]. Regional Revenue Breakdown - Revenue in the Americas for Q3 2025 was $35.4 million, a 28% increase from $27.7 million in Q3 2024 [10]. - Revenue in the EMEA region was $22.8 million, a 10% decrease from $25.2 million in Q3 2024 [10]. - Revenue in the Asia-Pacific region was $17.1 million, a 3% increase from $16.6 million in Q3 2024 [10]. Strategic Focus - The company emphasized its commitment to AI-powered innovation, which is enhancing its platform and competitive edge in the cloud security market [2]. - The growth in Cloud ARR and a healthy cloud security business position the company well for long-term growth opportunities [2].
Fangzhou and Fosun Pharma Forge Strategic Alliance to Deliver AI-Powered Psoriasis Management
Globenewswire· 2025-10-29 09:56
Core Insights - Fangzhou Inc. and Shanghai Fosun Pharmaceutical have signed a strategic collaboration agreement to enhance AI-driven chronic disease management, focusing initially on psoriasis and autoimmune conditions [1][2][5] Group 1: Strategic Collaboration - The partnership aims to develop flagship digital health initiatives that integrate AI-assisted patient education, academic research dissemination, digital marketing, and long-term disease management [2] - This collaboration supports the Healthy China 2030 initiative, emphasizing the importance of chronic disease management in public health [2] Group 2: Technology and Innovation - Fangzhou will leverage its proprietary "XingShi" Large Language Model and "AI+H2H" ecosystem alongside Fosun Pharma's Otezla® to create a comprehensive AI-powered psoriasis management system [3] - The system will enable precision assessment, personalized treatment, and ongoing care support for patients [3][4] Group 3: Market Impact and Future Plans - The partnership is expected to accelerate the digital transformation of pharmaceutical care, reshaping psoriasis management through AI-driven innovation [6] - Fangzhou plans to expand its "AI+" ecosystem beyond weight management to include psoriasis and other chronic diseases, contributing to a healthier China [7] Group 4: Company Background - Fangzhou Inc. serves 52.8 million registered users and 229,000 physicians, specializing in tailored medical care and AI-enabled precision medicine solutions [9] - Fosun Pharma, founded in 1994, is a leading global healthcare company involved in pharmaceuticals, medical devices, and healthcare services [8]
Notice of regulatory approval of the sale of Northern Horizon Capital AS shares
Globenewswire· 2025-10-29 09:35
Core Viewpoint - Northern Horizon Capital AS has received approval from the Estonian Financial Supervision and Resolution Authority for the sale of its shares to private investors, indicating a significant change in ownership structure [1][2]. Group 1: Transaction Details - The sale involves all 12,500 shares of Northern Horizon Capital AS, previously held by Northern Horizon A/S, to Antanas Anskaitis, Antanas Danys, and Tomas Milašauskas [1]. - This transaction follows the signing of a share purchase agreement with the partners of Grinvest on 21 August 2025, and is expected to be completed within 10 days of the approval [2]. Group 2: Company Background - Northern Horizon Capital AS manages the Baltic Horizon Fund, which is a registered contractual public closed-end real estate fund [3]. - Grinvest, the private investment firm involved in the transaction, has interests in commercial property, transportation, and infrastructure [4].
SUTNTIB AB Tewox publishes its factsheet for the third quarter of 2025
Globenewswire· 2025-10-29 09:10
Core Insights - SUTNTIB AB Tewox has published its factsheet detailing financial indicators and key events as of September 30, 2025 [1] Group 1: Key Events in Q3 2025 - Construction has commenced for three new grocery stores in Vilnius, Klaipėda, and Klaipėda district, with openings planned for 2026 [4] - The Vilnius store will have a Gross Leasable Area (GLA) of approximately 1,788 sqm, leased to the supermarket chain Iki, with a total investment of around 5 million EUR [4] - The Klaipėda store will feature a GLA of approximately 2,127 sqm, leased to Lidl, with a total investment projected at around 6 million EUR [4] - The grocery store in Klaipėda district will have a GLA of approximately 2,000 sqm, leased to Iki, with a total investment of around 5 million EUR [4] Group 2: Financial Performance - The company published its unaudited interim consolidated and separate financial statements for the first half of 2025 [4] - Consolidated operating income for the first half of 2025 reached 7 million EUR, while comprehensive income was 3.5 million EUR [4] - Total assets amounted to 179.6 million EUR as of the reporting period [4]
Late-breaking iMODERN findings presented at TCT 2025 and published in the New England Journal of Medicine highlight new evidence to guide treatment choices for heart attack patients
Globenewswire· 2025-10-29 09:00
Core Insights - Royal Philips announced results from the iMODERN trial, which evaluated the safety and effectiveness of immediate versus delayed treatment of additional narrowed arteries in heart attack patients [1][3][5] - The study found no significant difference in major outcomes between immediate treatment during the first procedure and staged treatment, providing evidence for both approaches [3][5][13] Group 1: iMODERN Trial Findings - The iMODERN trial is the largest study to date testing instantaneous wave-free ratio (iFR) in acute heart attack settings, enrolling 1,146 patients across 41 hospitals in 14 countries [5][3] - The main endpoint of the study combined three outcomes: death, another heart attack, or hospitalization for heart failure over three years, with no significant differences found between the two treatment strategies [5][3] - The results confirm that both immediate and staged treatment strategies are backed by solid evidence, allowing for more personalized care for patients [5][6] Group 2: Clinical Implications - The findings support current international guideline recommendations for complete revascularization in STEMI patients, integrating physiological assessment into treatment decisions [6][5] - The study provides cardiologists with the confidence to offer a complete solution in one session when appropriate, addressing a long-standing question in interventional cardiology [5][6] - Flexibility in treatment approaches is emphasized, as some patients may benefit from immediate treatment while others may be better served by waiting for further evaluation [6][5] Group 3: Related Studies - The ILIAS ANOCA study presented at the same conference demonstrated the value of physiology-guided decision-making in patients with angina and no obstructive coronary arteries, showing significant improvements in patient-reported symptoms [7][8] - The ILIAS ANOCA study involved 153 patients and confirmed the benefits of tailored therapy guided by coronary function testing [8][7] Group 4: Technology Utilization - Philips' iFR technology and advanced cardiac MRI were utilized in the iMODERN trial to guide treatment decisions, supporting the generation of robust evidence for clinical practice [9][10] - The integration of these technologies allows for both invasive and non-invasive approaches in evaluating treatment strategies for heart attack patients [9][10]